中國銀河(601881.SH)半年度歸母淨利潤預增15%-20%
格隆匯7月1日丨中國銀河(601881.SH)公佈,公司預計2021年上半年歸屬於母公司股東的淨利潤與上年同期相比,將增加人民幣53286.62萬元到71048.82萬元,同比增長15%到20%;歸屬於上市公司股東的扣除非經常性損益的淨利潤與上年同期相比,將增加53868.32萬元到71824.43萬元,同比增加15%到20%。
2021年上半年,公司堅持踐行“雙輪驅動,協同發展”的業務模式,在財富管理、投資業務、國際業務、期貨業務等方面均穩步增長,公司歸屬於母公司股東的淨利潤同比增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.